Table 1 The association between ERβ/ CLDN6/ beclin1 expression and clinical characteristics of breast cancer patients
Characteristic | ERβ | p | CLDN6 | p | Beclin1 | p | |||
|---|---|---|---|---|---|---|---|---|---|
High | Low | High | Low | High | Low | ||||
Age | 0.932 | 0.923 | 0.697 | ||||||
≤57 years | 11 | 22 | 13 | 20 | 8 | 11 | |||
>57 years | 11 | 23 | 13 | 21 | 12 | 13 | |||
Pathology grade | 0.785 | 0.717 | 0.960 | ||||||
I-II | 10 | 19 | 11 | 19 | 7 | 11 | |||
II-III | 11 | 18 | 9 | 19 | 8 | 13 | |||
Tumour size | 0.451 | 0.716 | 0.026 | ||||||
≤3 cm | 13 | 29 | 16 | 25 | 15 | 10 | |||
>3 cm | 10 | 15 | 9 | 17 | 5 | 14 | |||
Lymph node | 0.314 | 0.088 | 0.899 | ||||||
Negative | 8 | 24 | 12 | 20 | 11 | 14 | |||
Positive | 9 | 15 | 4 | 20 | 6 | 7 | |||
TNM stage | 0.023 | 0.356 | 0.947 | ||||||
0-II | 13 | 37 | 20 | 30 | 14 | 20 | |||
III-IV | 10 | 8 | 5 | 13 | 4 | 6 | |||